Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Codeine phosphate + guaifenesin is a combination pharmaceutical drug used primarily to relieve cough and loosen mucus in conditions such as the common cold or allergies. Codeine is an opioid that acts centrally on the medulla to suppress the cough reflex, while guaifenesin is an expectorant that thins and loosens bronchial secretions, making it easier to clear mucus from the airways. This combination provides both symptomatic relief of cough (via central suppression) and improved clearance of respiratory secretions (via increased fluidity). Codeine has potential for dependence and should be used only as prescribed for short durations[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on codeine phosphate + guaifenesin.